Needham analyst N.

Quinn Bolton raised the price target on Marvell (NASDAQ: MRVL) to $400 (from $300) while maintaining a Buy rating.

“Yesterday, we attended Marvell’s 2026 Analyst Day in NYC.

Our key takeaways include: 1) The company provided a long-term model targeting $70-90BN of revenue and >$30 of NG EPS in FY31; 2) At the FY31 revenue midpoint of $80BN, interconnect is expected to account for ~$37.5BN, Custom is projected at ~$30BN, Switching and Storage is forecast to reach ~$10BN, and Comms and Other is anticipated to hold flat at ~$2.5BN; 3) the FY28 revenue outlook was raised to $20BN (from $18BN), driven by the data center connectivity portfolio; and 4) The company raised its FY29 custom revenue target to >$12BN (from ~$10BN), supported by semi-custom and IP-led solutions across networking, storage, memory, security, and inference acceleration.

We increase our 12-month PT to $400, based on a ~31x P/E multiple of our new CY28 NG EPS estimate of $13.00.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

This callScored on Apr 8, 2027, six months after the note: did MRVL reach $400?

Firm track recordNeedham reached 86% of its 14 scored targets within six months (#1 of 31 firms). Accuracy ranking →

Needham on Marvell · target history
May 28, 2026 · $270 · Buy Aug 28, 2026 · $300 · Buy Oct 7, 2026 · $400 · Buy · this note
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.